After Novartis and Roche grew their sales last year, the Swiss pharma giants are handing their CEOs larger compensation packages for 2024. | After Novartis and Roche grew their sales last year, the ...
Roche announced this morning that its head of pharmaceuticals, Bill Anderson, is leaving the company to pursue "other opportunities" after four years in the role. Anderson will be replaced in the ...
If anything, the gap understates the gulf between the soft-spoken, beetle-browed Hoffmann, who is the great-grandson of Fritz Hoffmann-La Roche, founder of pharmaceuticals group Roche, and the ...
Roche projected to claim pharma's 2025 sales crown as Novo, Lilly climb rankings: Evaluate Nonetheless, Roche’s pharma chief Teresa Graham put Itovebi’s peak sales potential at 2 billion Swiss ...
Roche tells Andrew McConaghie that inaccurate reports of its price have distorted the debate. Just as US pharma is once again ... price cuts it offers to the Department of Health bring it down ...
Late-stage trial data for Roche’s drug against muscle-wasting Elevidys showed positive results after two years of treatment for male patients aged 4 or older with Duchenne muscular dystrophy.
PUTRAJAYA: Swiss healthcare giant Roche Pharmaceuticals has picked Malaysia's Sarawak General Hospital as its global First-in-Human (FIH) clinical trial site. Malaysia will be the seventh country ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback